what is glp-1 drugs Agonists: A Comprehensive Overview GLP-1 Medications for Weight Loss

This significantly reduces the long-term risk of heart attack and stroke

However, in the context of DPN, this pathway appears to malfunction, leading to the production of excessive inflammatory molecules

Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes

There do not appear to be any other ongoing large kidney outcome trials researching GLP-1 receptor agonists or newer dual or triple agonists, but it will be exciting to see in the future the results of smaller ongoing trials and hopefully additional large prospective clinical trials with kidney outcomes

Introduction GLP-1 receptor agonists, a new generation of weight loss drugs, are transforming the treatment of Type 2 diabetes and obesity